60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant(SXTPW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SXTPW 60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant

盘前交易 01-23 07:05:28 EST

0.1020

+0.0422

+70.57%

最高0.1499	最低0.1003	成交量12.19万
今开0.1175	昨收0.0598	日振幅82.94%
总市值41.87万	流通市值41.87万	总股本410.45万
成交额1.46万	换手率2.97%	流通股本410.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SXTPW","market":"US","secType":"STK","nameCN":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant","latestPrice":0.102,"timestamp":1769115600000,"preClose":0.0598,"halted":0,"volume":121919,"delay":0,"changeRate":0.705685618729097,"floatShares":4104469,"shares":4104469,"eps":0,"marketStatus":"盘前交易","change":0.0422,"latestTime":"01-23 07:05:28 EST","open":0.1175,"high":0.1499,"low":0.1003,"amount":14632.896382,"amplitude":0.829431,"askPrice":0,"askSize":0,"bidPrice":0.05,"bidSize":400,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769178600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.119,"postHourTrading":{"tag":"盘后","latestPrice":0.102,"preClose":0.102,"latestTime":"16:03 EST","volume":1250,"amount":127.5,"timestamp":1769115818847,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":83.96625170868626},"requestUrl":"/m/hq/s/SXTPW","defaultTab":"news","newsList":[{"id":"1111655792","title":"60 Degrees Pharmaceuticals携手Runway Health为国际旅行者提供疟疾预防药物Arakoda®直供服务","url":"https://stock-news.laohu8.com/highlight/detail?id=1111655792","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111655792?lang=zh_cn&edition=full","pubTime":"2026-01-22 21:02","pubTimestamp":1769086950,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals与Runway Health达成战略合作，将共同为国际旅行者开辟Arakoda疟疾预防药物的直接获取渠道。该合作旨在通过数字化健康平台，为出境人员提供便捷的疟疾预防解决方案。此次合作将整合60 Degrees Pharmaceuticals在热带病防治领域的专业优势与Runway Health的创新医疗服务平台，确保旅行者能够及时获得经临床验证的疟疾预防药物。Arakoda作为美国FDA批准的新型疟疾预防药物，其便捷的用药方案特别适合长期跨境旅行者需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007","SXTPW"],"gpt_icon":0},{"id":"1145415013","title":"60度制药公司赞助研究显示：北卡罗来纳州立大学同行评审发现24%慢性疲劳患者存在巴贝西虫感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1145415013","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145415013?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:02","pubTimestamp":1767013374,"startTime":"0","endTime":"0","summary":"一项由60度制药公司资助、在北卡罗来纳州立大学开展的同行评审研究揭示，在表现为慢性疲劳症状的患者群体中，巴贝西虫感染的检出率高达24%。该研究成果为慢性疲劳综合征与寄生虫感染之间的潜在关联提供了新的临床证据。\n研究数据表明，近四分之一长期受困于不明原因疲劳的患者，其症状可能与巴贝西虫属原虫感染存在病理学联系。这一发现不仅为慢性疲劳的病因诊断开辟了新视角，也可能推动相关靶向治疗方案的开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007","SXTPW"],"gpt_icon":0},{"id":"1104126707","title":"60 Degrees Pharmaceuticals 宣布 B-Free 慢性巴贝斯病研究的临床试验中心已开放病人入组，地点位于西奈山伊坎医学院","url":"https://stock-news.laohu8.com/highlight/detail?id=1104126707","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104126707?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:01","pubTimestamp":1763730076,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals 宣布 B-Free 慢性巴贝斯病研究的临床试验中心现已开放病人入组，地点位于西奈山伊坎医学院。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007","SXTPW"],"gpt_icon":0},{"id":"1144509557","title":"60 Degrees Pharmaceuticals宣布在复发性巴贝斯虫病研究中，首位患者接受塔非喹治疗后未发现巴贝斯虫感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1144509557","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144509557?lang=zh_cn&edition=full","pubTime":"2025-10-15 19:15","pubTimestamp":1760526909,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals宣布在复发性巴贝斯虫病研究中，首位患者接受塔非喹治疗后未发现巴贝斯虫感染。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007","SXTPW"],"gpt_icon":0},{"id":"1194045758","title":"60 Degrees Pharmaceuticals公布慢性巴贝西亚病临床试验名称：B-Free慢性巴贝西亚病研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1194045758","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194045758?lang=zh_cn&edition=full","pubTime":"2025-10-09 19:32","pubTimestamp":1760009565,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals公布慢性巴贝西亚病临床试验名称：B-Free慢性巴贝西亚病研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP","SXTPW"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.8545},{"period":"1month","weight":1.3235},{"period":"3month","weight":1.0198},{"period":"6month","weight":1.2896},{"period":"1year","weight":2.4},{"period":"ytd","weight":0.6242}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0173},{"period":"6month","weight":0.0814},{"period":"1year","weight":0.1361},{"period":"ytd","weight":0.0104}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"NASDAQ","name":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant","nameEN":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant(SXTPW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant(SXTPW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant,SXTPW,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股票,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股票老虎,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股票老虎国际,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant行情,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股票行情,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股价,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股市,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股票价格,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股票交易,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股票购买,60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant(SXTPW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant(SXTPW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}